Title: The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans.
Journal: Life sciences 20121015
Title: Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Journal: Journal of cardiovascular pharmacology 20041101
Title: [Physiological and pathophysiological roles of the endothelin converting enzymes].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040901
Title: Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure.
Journal: The American journal of cardiology 20040715
Title: SLV-306. Solvay.
Journal: Current opinion in investigational drugs (London, England : 2000) 20030301